Mission

Contribute to the Healthy Lives of People

Vision

The Frontier Company in Genomic Diagnostics

 

GC Genome

GC Genome was established in August 2013

as a new member of GC Family 

specializing in Clinical Genomics. 

Setting itself apart from the other players that only focus on the deciphering of DNA sequences for research purposes, 

GC Genome is moving toward the goal of utilizing genomic information for disease diagnosis, disease screening and also precision medicine. 

GC Genome leverages on the most up to date technologies including Next-Generation Sequencing (NGS) to provide distinguished services with shortened turnaround time, and affordable prices. 

Moreover, we continue to invest heavily on R&D activities to develop services to fulfill the unmet needs of people and participate in the advancement of various global and national research projects.

 

Keep an eye out for GC Genome as we develop into a frontier company in genomic diagnostics and we will answer your support with our endless efforts and challenges.  

Thank you.

 
History

2019

Launched GreenBiome Gut (Microbiome Test) 10

 

Launched Distribution of Guardant 360 in Korea 07

2017

Selected as the Supervisory Institution for Korea-Czech Republic 11 Global R&D Cooperation project    

Selected for Bio-industry Core R&D Project 10

Obtained KFDA Certification of Clinical NGS Laboratory 04

Obtained CAP accreditation 02

2015

Launched Pharmacogenetic Test 11

Selected as supervisory institution for Korea Post-Genome  08  Project     

Obtained Level A (best accuracy) from the Korea Institute of 07 Genetic Testing Evaluation    

Launched G-NIPT (Non-invasive prenatal Test) 04

2013

Genome Research Center approved by the Korean Government 12

GC Genome Established 08

2018

10 Obtained CAP accreditation (2nd time)

04 Launched NGS-based preventive screening test Genome Screen (1st in Korea)

2016

12 Registered patent for G-NIPT

09 Launched i-screen (Newborn Genome Screening Test)

2014

04 Launched series of clinical genetic test items

  - Diagnostic Exome Sequencing Service (1st in Korea) for rare disease patients

  - Type 1 Myotonic Dystrophy carrier screening

  - Hereditary Cancer Test

107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 16924, Korea

Email. info.gcgenome@gccorp.com Tel. +82 31-280-9900   Fax. +82 31-260-9087

©2020 by GC Genome.